Published By: | October 12, 2018
Stock Buybacks vs Diversified Dividends
Authored By: Carleen Kay | Publish Date: October 11, 2018
Employers are facing new challenges when it comes to substances used by employees both in and out of the workplace. What employers should consider in ensuring a safe workplace and that employees go home safely each day was the focus of a CPBI Alberta South session focused on the science of cannabis and the employer’s role in managing absence and disability related to substance use disorders.Read More
Published By: | October 5, 2018
How much money do you need for a financially healthy retirement? Can your retirement savings keep up with inflation? How will market volatility impact your nest egg? And the biggest question of all: How long will my money last?
Authored By: Josh Lohmeier | Publish Date: October 3, 2018
Has the decades-long bull market in bonds made some credit managers look better than they really are? In the favourable market environment of the past 30 years, many managers found success simply by taking on additional risk and not necessarily adding much value.Read More
Authored By: Joseph Nunes | Publish Date: October 1, 2018
Most sponsors of individual pension plans (IPPs) are sold a product intended to achieve one or more goals, such as targeting a certain retirement income, rewarding long and loyal service, or creating ‘golden handcuffs’ to retain key employees. Embedded in the many possible goals is almost always the desire to tax-shelter more dollars for an employee than is possible under an RRSP.Read More
Published By: HSBC Global Asset Management | September 18, 2018
Investors are seeking equity solutions that incorporate climate considerations. Reducing a portfolio’s carbon footprint by exclusion is a blunt approach. We prefer factor optimisation in multi-factor portfolios, which can generate higher risk-adjusted returns while keeping portfolios aligned with broader climate objectives.
Published By: Personalized Prescribing Inc. | September 17, 2018
Pharmacogenomics- Not a concept for the future, it is a REALITY Now! This changed the traditional “one size fits to all” method of prescribing to one that is personalized. Pharmacogenomics is an excellent tool for employers/ disability managers to address employee’s drug related disability or absenteeism.
Published By: | August 27, 2018
Author: Brent Joyce, chief investment strategist at GLC Asset Management.
It’s official. Born from the depths of the country’s worst financial crisis, and fueled by historically low interest rates, unprecedented government interventions, and blossoming global technology giants like Facebook and Amazon, comes the longest bull market the U.S. has ever seen (3,453 calendar days to be precise). The S&P 500 hit 2861.82 today, a 323% gain from its low in March 2009
Published By: Express Scripts | August 3, 2018
The Prescription Drug Trend Report by Express Scripts Canada found that private plan spending on prescription drugs continues to climb, and that high-cost drugs and patients undermine the ability of employers to offer an affordable prescription drug benefit to employees. However, there are measures employers can take to control costs while improving health outcomes for their employees.
Published By: HSBC Global Asset Management | August 2, 2018
So, with everything going up and up, what could happen to a multi-asset portfolio when financial markets experience a bit of a wobble? Will diversification still add value?